n-(2-hydroxypropyl)methacrylamide has been researched along with Angiogenesis, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
David, A; Feinshtein, V; Zaiden, M | 1 |
Hovorka, O; Pechar, M; Pola, R; Ríhová, B; Studenovský, M; Ulbrich, K; Vetvicka, D | 1 |
2 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Angiogenesis, Pathologic
Article | Year |
---|---|
Inhibition of CD44v3 and CD44v6 function blocks tumor invasion and metastatic colonization.
Topics: Acrylamides; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Drug Delivery Systems; Female; Humans; Hyaluronan Receptors; Male; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptides; Prostatic Neoplasms; Tissue Distribution | 2017 |
HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides.
Topics: Acrylamides; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Drug Delivery Systems; Endothelium, Vascular; Humans; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Time Factors | 2009 |